A

Affinivax Inc.

78 employees

Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical
Pharmaceutical

Date founded

2014

Funding rounds raised

Total raised

$226M

from 10 investors over 10 rounds

A

Affinivax Inc. raised $22M on March 9, 2021

Investors: CARB-X

A

Affinivax Inc. raised $226M on January 8, 2021

Investors: Foresite Capital, Surveyor Capital, Viking Global Investors, T. Rowe Price, Wellington Management, Logos Global Management, LP and Perceptive Advisors

A

Affinivax Inc. raised $120M on April 23, 2020

Investors: Viking Global Investors

A

Affinivax Inc. raised $2.5M on February 5, 2016

Investors: Bill & Melinda Gates Foundation

FAQ